Biogen Idec is investigating long-acting, fully-recombinant clotting factors with the potential to empower people with hemophilia to live the lives they choose.
Find out about our
clinical programs
Watch an animation about
our Fc fusion technology,
now with narration
News
Recent news about Biogen Idec's hemophilia therapeutic area
Meetings
Hemophilia World Congress
July 10-14, 2010
Buenos Aires, Argentina
National Hemophilia Foundation
Annual Meeting
November 11-13, 2010
New Orleans, LA
About
Learn more about
hemophilia A and B
Visit Biogen Idec for more information about other products and the pipeline
Features
Download the
Distance Challenge
Xtreme video game
© Biogen Idec |
Terms & Conditions of Use
|
Note Regarding Forward-Looking Statements
|
Privacy Policy
|
Site Map
About
|
Technology
|
Pipeline
|
Hemophilia
|
Clinical Programs
|
Community
|
Other
|
Careers
|
Contact Us
